BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

High NDRG3 expression facilitates HCC metastasis by promoting nuclear translocation of β-catenin

  • Shi, JiKui (Department of Critical Care Medicine, Jining NO.1 People's Hospital) ;
  • Zheng, HongZhen (Department of Oncology, Changzheng Hospital, Second Military Medical University) ;
  • Yuan, LingYan (Department of Oncology, Changzheng Hospital, Second Military Medical University)
  • Received : 2018.08.31
  • Accepted : 2018.10.31
  • Published : 2019.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

NDRG1 has been reported to exert pivotal roles in tumor progression and metastasis via Wnt/${\beta}$-catenin signaling pathway. However, little is known about the role of NDRG3 in hepatocarcinogenesis despite its classification in the same subfamily of NDRG1. The present study was aimed to characterize the expression pattern and understand the biological roles of NDRG3 in hepatocarcinogenesis, as a means to exploit its therapeutic potential. It was observed that NDRG3 was up-regulated in HCC tissues and higher NDRG3 expression was associated with significantly shorter overall survival. Furthermore, a lower level of NDRG3 exhibited marked positive correlation with metastasis-free survival. In vitro and in vivo experiments revealed that knock-down of NDRG3 inhibits HCC metastasis and angiogenesis. We further demonstrated that activation of WNT/${\beta}$-catenin signaling and enhanced CSC-like properties were responsible for NDRG3-mediated promoting effect on HCC. In conclusion, the principal findings demonstrated that high NDRG3 expression facilitates HCC metastasis via regulating the turnover of ${\beta}$-catenin, as well as provides a potential therapeutic target for future therapeutic interventions.

Keywords

References

  1. Altekruse SF, Henley SJ, Cucinelli JE and McGlynn KA (2014) Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol 109, 542-553 https://doi.org/10.1038/ajg.2014.11
  2. Kim SR, Kudo M, Hino O et al (2008) Epidemiology of hepatocellular carcinoma in Japan and Korea. A review. Oncology 75 Suppl 1, 13-16 https://doi.org/10.1159/000173419
  3. Zhu AX (2010) Systemic treatment of hepatocellular carcinoma: dawn of a new era? Ann Surg Oncol 17, 1247-1256 https://doi.org/10.1245/s10434-010-0975-6
  4. Okuda T and Kondoh H (1999) Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc. Biochem Biophys Res Commun 266, 208-215 https://doi.org/10.1006/bbrc.1999.1780
  5. Zhao W, Tang R and Huang Y (2001) Cloning and expression pattern of the human NDRG3 gene. Biochim Biophys Acta 1519, 134-138 https://doi.org/10.1016/S0167-4781(01)00210-X
  6. Shimono A, Okuda T and Kondoh H (1999) N-mycdependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev 83, 39-52 https://doi.org/10.1016/S0925-4773(99)00025-8
  7. Zhou RH, Kokame K, Tsukamoto Y, Yutani C, Kato H and Miyata T (2001) Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73, 86-97 https://doi.org/10.1006/geno.2000.6496
  8. Qu X, Zhai Y, Wei H et al (2002) Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 229, 35-44 https://doi.org/10.1023/A:1017934810825
  9. Melotte V, Qu X, Ongenaert M et al (2010) The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. FASEB J 24, 4153-4166 https://doi.org/10.1096/fj.09-151464
  10. Ulrix W, Swinnen JV, Heyns W and Verhoeven G (1999) The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett 455, 23-26 https://doi.org/10.1016/S0014-5793(99)00845-5
  11. Lee GY, Chun YS, Shin HW and Park JW (2016) Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia. Oncotarget 7, 57442-57451 https://doi.org/10.18632/oncotarget.10684
  12. Bandyopadhyay S, Wang Y, Zhan R et al (2003) The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63, 1731-1736
  13. Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM and Pardee AB (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60, 749-755
  14. Stein S, Thomas EK, Herzog B et al (2004) NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279, 48930-48940 https://doi.org/10.1074/jbc.M400386200
  15. Lu WJ, Chua MS, Wei W and So SK (2015) NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3OI and Nur77 to prevent OI-catenin degradation. Oncotarget 6, 29847-29859 https://doi.org/10.18632/oncotarget.4913
  16. Mitchelmore C, Buchmann-Moller S, Rask L, West MJ, Troncoso JC and Jensen NA (2004) NDRG2: a novel Alzheimer's disease associated protein. Neurobiol Dis 16, 48-58 https://doi.org/10.1016/j.nbd.2004.01.003
  17. Deng Y, Yao L, Chau L et al (2003) N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer 106, 342-347 https://doi.org/10.1002/ijc.11228
  18. Kim YJ, Yoon SY and Kim JT (2009) NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells. Int J Cancer 124, 7-15 https://doi.org/10.1002/ijc.23945
  19. Melotte V, Lentjes MH, van den Bosch SM et al (2009) N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst 101, 916-927 https://doi.org/10.1093/jnci/djp131
  20. Schilling SH, Hjelmeland AB, Radiloff DR et al (2009) NDRG4 is required for cell cycle progression and survival in glioblastoma cells. J Biol Chem 284, 25160-25169 https://doi.org/10.1074/jbc.M109.012484
  21. Yang Q, Zhang X, Shi Y et al (2017) Increased Expression of NDRG3 in Mouse Uterus During Embryo Implantation and in Mouse Endometrial Stromal Cells During In Vitro Decidualization. Reprod Sci 25, 1197-1207 https://doi.org/10.1177/1933719117737843
  22. Okuda T, Kokame K and Miyata T (2008) Differential expression patterns of NDRG family proteins in the central nervous system. J Histochem Cytochem 56, 175-182 https://doi.org/10.1369/jhc.7A7323.2007
  23. Cui C, Lin H, Shi Y and Pan R (2017) Hypoxic postconditioning attenuates apoptosis via inactivation of adenosine A2a receptor through NDRG3-Raf-ERK pathway. Biochem Biophys Res Commun 491, 277-284 https://doi.org/10.1016/j.bbrc.2017.07.112
  24. Yao Y, Wang W, Jing L et al (2017) Let-7f Regulates the Hypoxic Response in Cerebral Ischemia by Targeting NDRG3. Neurochem Res 42, 446-454 https://doi.org/10.1007/s11064-016-2091-x
  25. Luo X, Hou N, Chen X et al (2017) High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer. Cancer Biomark 21, 461-469
  26. Ma J, Liu S, Zhang W et al (2016) High expression of NDRG3 associates with positive lymph node metastasis and unfavourable overall survival in laryngeal squamous cell carcinoma. Pathology 48, 691-696 https://doi.org/10.1016/j.pathol.2016.08.005
  27. Estiar MA, Zare AA, Esmaeili R et al (2017) Clinical significance of NDRG3 in patients with breast cancer. Future Oncol 13, 961-969 https://doi.org/10.2217/fon-2016-0457
  28. Liu W, Iiizumi-Gairani M, Okuda H et al (2011) KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer. J Biol Chem 286, 18949-18959 https://doi.org/10.1074/jbc.M111.232637
  29. Liu W, Yue F, Zheng M et al (2015) The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1. Oncotarget 6, 8851-8874 https://doi.org/10.18632/oncotarget.3316
  30. Mi L, Zhu F, Yang X et al (2017) The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells. Oncogene 36, 4323-4335 https://doi.org/10.1038/onc.2017.74
  31. Akiba J, Ogasawara S, Kawahara A et al (1994) N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma. Oncol Rep 20, 1329-1335
  32. Du Z, Niu S, Xu X and Xu Q (2017) MicroRNA31-NDRG3 regulation axes are essential for hepatocellular carcinoma survival and drug resistance. Cancer Biomark 19, 221-230 https://doi.org/10.3233/CBM-170568